Endoscopic Perfusion Utilizing ICG Fluorescence Technology

Completed

Conditions studied: Quality of Life

In brief

The main objective of the study is to evaluate the efficacy of indocyanine green (ICG) endoscopy to evaluate tissue perfusion during endoscopic neurosurgery. This includes patients with pituitary and intracranial tumors and treatment of vascular abnormalities such as aneurysms and compressive syndromes. ICG will be evaluated to determine the value of the additional visual information supplied during the treatment of these pathologies.

Key facts

Study ID

NCT02383628

Run by

University of Pittsburgh

People needed

197

Starts

2015-10-01

Expected to finish

2018-06-01

Last updated by the study team

2018-07-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient population would include those patients with pituitary tumors, intracranial tumors, aneurysms, and normal tissue adjacent to tumors to clarify normal from abnormal. Also, patients with compressive syndromes to ensure patency of normal vessels. This would be all patients undergoing endoscopic surgery, both endonasal and open (retromastoid or transcranial).

You may not qualify if…

• Less than 18 years of age
• Iodine allergy
• Shellfish allergy
• Contrast allergy
• Previous anaphylactic reaction to ICG
• Pregnant
• Anyone with any evidence of renal or hepatic dysfunction

Where it is running

• University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.